Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anti-PD1 Monotherapy in 1L Advanced NSCLC Patients With PD-L1 TPS > 50% and PTI=0

NCT07360743 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.

NCT NCT07360743
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07360743 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anti-PD1 Monotherapy in 1L Advanced NSCLC Patients With PD-L1 TPS > 50% and PTI=0
Lead sponsor
UNICANCER
Phase
Phase 2
Overall status
Recruiting
Start date
August 21, 2026
Completion date
April 30, 2032
Enrollment
275 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

non small cell lung cancer (squamous or non squamous)